Literature DB >> 24661844

Citrate metabolism and its complications in non-massive blood transfusions: association with decompensated metabolic alkalosis+respiratory acidosis and serum electrolyte levels.

Zafer Bıçakçı1, Lale Olcay2.   

Abstract

BACKGROUND AND OBJECTIVES: Metabolic alkalosis, which is a non-massive blood transfusion complication, is not reported in the literature although metabolic alkalosis dependent on citrate metabolism is reported to be a massive blood transfusion complication. The aim of this study was to investigate the effect of elevated carbon dioxide production due to citrate metabolism and serum electrolyte imbalance in patients who received frequent non-massive blood transfusions.
MATERIALS AND METHODS: Fifteen inpatients who were diagnosed with different conditions and who received frequent blood transfusions (10-30 ml/kg/day) were prospectively evaluated. Patients who had initial metabolic alkalosis (bicarbonate>26 mmol/l), who needed at least one intensive blood transfusion in one-to-three days for a period of at least 15 days, and whose total transfusion amount did not fit the massive blood transfusion definition (<80 ml/kg) were included in the study.
RESULTS: The estimated mean total citrate administered via blood and blood products was calculated as 43.2 ± 34.19 mg/kg/day (a total of 647.70 mg/kg in 15 days). Decompensated metabolic alkalosis+respiratory acidosis developed as a result of citrate metabolism. There was a positive correlation between cumulative amount of citrate and the use of fresh frozen plasma, venous blood pH, ionized calcium, serum-blood gas sodium and mortality, whereas there was a negative correlation between cumulative amount of citrate and serum calcium levels, serum phosphorus levels and amount of urine chloride.
CONCLUSION: In non-massive, but frequent blood transfusions, elevated carbon dioxide production due to citrate metabolism causes intracellular acidosis. As a result of intracellular acidosis compensation, decompensated metabolic alkalosis+respiratory acidosis and electrolyte imbalance may develop. This situation may contribute to the increase in mortality. In conclusion, it should be noted that non-massive, but frequent blood transfusions may result in certain complications.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carbon dioxide; Citrate metabolism; Electrolyte imbalance; Metabolic alkalosis; Respiratory acidosis

Mesh:

Substances:

Year:  2014        PMID: 24661844     DOI: 10.1016/j.transci.2014.03.002

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  4 in total

1.  Plasma Citrate Homeostasis: How It Is Regulated; And Its Physiological and Clinical Implications. An Important, But Neglected, Relationship in Medicine.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  HSOA J Hum Endocrinol       Date:  2016-12-31

2.  Forgot calcium? Admission ionized-calcium in two civilian randomized controlled trials of prehospital plasma for traumatic hemorrhagic shock.

Authors:  Hunter B Moore; Matthew T Tessmer; Ernest E Moore; Jason L Sperry; Mitchell J Cohen; Michael P Chapman; Anthony E Pusateri; Francis X Guyette; Joshua B Brown; Matthew D Neal; Brian Zuckerbraun; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2020-05       Impact factor: 3.313

3.  Modified regional citrate anticoagulation is optimal for hemodialysis in patients at high risk of bleeding: a prospective randomized study of three anticoagulation strategies.

Authors:  Ting Lin; Li Song; Renwei Huang; Ying Huang; Shuifu Tang; Qizhan Lin; Ying Zhang; Xingbo Wu; Hui Liang; Yuchi Wu; Yuanhan Chen; Huaban Liang; Jianchao Ma; Zhonglin Feng; Zhuo Li; Lixia Xu; Xia Fu; Zhiming Ye; Shuangxin Liu; Xinling Liang
Journal:  BMC Nephrol       Date:  2019-12-19       Impact factor: 2.388

4.  Unravelling the Effect of Citrate on the Features and Biocompatibility of Magnesium Phosphate-Based Bone Cements.

Authors:  Rita Gelli; Gemma Di Pompo; Gabriela Graziani; Sofia Avnet; Nicola Baldini; Piero Baglioni; Francesca Ridi
Journal:  ACS Biomater Sci Eng       Date:  2020-09-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.